EUVIMEDEUVIMED entdecken
Crossref

Obesity history exacerbates liver macrophage-mediated fibrosis via IGFBP7

Shindy Soedono, SungWan Chun, Dan Hoang Nguyet Vo, Vivi Julietta, Jiyeon Chang, Byung-Chul Oh, Carey N Lumeng, Kae Won Cho

Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · 2026-10 · 1872 (7) · 168322

DOI: 10.1016/j.bbadis.2026.168322 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2026-10. Verfasst von Shindy Soedono und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Integrated Biomedical Science, Soonchunhyang University, Cheonan, Republic of Korea; Soonchunhyang Institute of Medi-Bio Science (SIMS)…. Hauptthemen laut MEDLINE: Obesity, Macrophages, Liver Cirrhosis, Insulin-Like Growth Factor Binding Proteins. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 53 Literaturangaben. Gefördert von: National Research Foundation of Korea, Korea Basic Science Institute, Korean Society for the Study of Obesity.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Weight regain is a frequent outcome after lifestyle-induced weight loss and is closely linked to the progression of metabolic dysfunction-associated steatotic liver disease (MASLD). However, the mechanisms by which prior obesity predisposes to metabolic dysfunction-associated steatohepatitis (MASH) development remain unclear. This study investigates how obesity history influences hepatic steatosis and fibrosis during weight regain. A diet-switch model was used to establish obesity, weight loss (WL), weight regain (RCHFD), and short-term obesity (STHFD) conditions, enabling comparisons between groups with and without prior obesity. Hepatic fibrosis during weight regain was induced using carbon tetrachloride (CCl4) alongside a second high-fat diet challenge. Obesity history exacerbated hepatic fibrosis during weight regain in the CCl4 model, accompanied by pronounced liver macrophage (Mφ) activation. Even without CCl4 treatment, RCHFD mice displayed worsened hepatic steatosis and fibrosis compared to mice without prior obesity, associated with sustained liver Mφ accumulation. Despite the resolution of steatosis and inflammation after weight loss, Mφ persistence coincided with continuous hepatic stellate cell (HSC) activation, as evidenced by elevated alpha-smooth muscle actin (α-SMA) expression. Co-culture studies revealed that liver Mφs from WL mice could activate HSCs, recapitulating the effects of obesity. Mechanistically, IGFBP7 was upregulated in liver Mφs during both obesity and WL, and its secretion mediated HSC activation. These findings demonstrate that obesity history accelerates MASH progression during weight regain through a macrophage/IGFBP7/HSC axis. Targeting IGFBP7 may represent a potential therapeutic approach to prevent fibrosis progression in individuals with a history of obesity.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ObesityMacrophagesLiver CirrhosisInsulin-Like Growth Factor Binding ProteinsLiverAnimalsMiceMaleHepatic Stellate CellsCarbon TetrachlorideDiet, High-FatFatty LiverMice, Inbred C57BLNon-alcoholic Fatty Liver DiseaseWeight Gain

Stichwörter der Autor:innen

FibrosisMacrophagesMetabolic dysfunction-associated steatohepatitis (MASH)Metabolic dysfunction-associated steatotic liver disease (MASLD)ObesityWeight cycling

Substanzen

Insulin-Like Growth Factor Binding Proteinsinsulin-like growth factor binding protein-related protein 1Carbon Tetrachloride

Autor:innen und Institutionen

  • Department of Integrated Biomedical Science, Soonchunhyang University, Cheonan, Republic of Korea; Soonchunhyang Institute of Medi-Bio Science (SIMS), Soonchunhyang University, Cheonan, Republic of Korea.
  • Department of Internal Medicine, Soonchunhyang University Cheonan Hospital, Cheonan, Republic of Korea.
  • Lee Gil Ya Cancer and Diabetes Institute, Department of Physiology, College of Medicine, Gachon University, Incheon, Republic of Korea.
  • Department of Pediatrics, University of Michigan Medical School, Ann Arbor, MI, USA; Molecular and Integrative Physiology, University of Michigan Medical School, Ann Arbor, MI, USA. Electronic address: clumeng@umich.edu.
  • Department of Integrated Biomedical Science, Soonchunhyang University, Cheonan, Republic of Korea; Soonchunhyang Institute of Medi-Bio Science (SIMS), Soonchunhyang University, Cheonan, Republic of Korea. Electronic add…

Förderung

  • National Research Foundation of Korea
  • Korea Basic Science Institute
  • Korean Society for the Study of Obesity
  • Korean Diabetes Association
  • Ministry of Education

Zitieren

APA

Soedono, S., Chun, S., Vo, D. H. N., Julietta, V., Chang, J., Oh, B. C., Lumeng, C. N., & Cho, K. W. (2026). Obesity history exacerbates liver macrophage-mediated fibrosis via IGFBP7. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 1872(7), 168322. https://doi.org/10.1016/j.bbadis.2026.168322

Vancouver

Soedono S, Chun S, Vo DHN, Julietta V, Chang J, Oh BC, et al. Obesity history exacerbates liver macrophage-mediated fibrosis via IGFBP7. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 2026;1872(7):168322. doi:10.1016/j.bbadis.2026.168322

BibTeX
@article{Soedono2026,
  author = {Soedono, Shindy and Chun, SungWan and Vo, Dan Hoang Nguyet and Julietta, Vivi and Chang, Jiyeon and Oh, Byung-Chul and Lumeng, Carey N and Cho, Kae Won},
  title = {Obesity history exacerbates liver macrophage-mediated fibrosis via IGFBP7},
  journal = {Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease},
  year = {2026},
  volume = {1872},
  number = {7},
  pages = {168322},
  doi = {10.1016/j.bbadis.2026.168322}
}
Kostenlos starten →